Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Pulmonary Hypertension in Thalassemia
NCT00872170Phase 3Completed
- Sponsor
- Elevance Health
- Start
- Mar 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in pulmonary hypertension (PH), sponsored by Elevance Health. Started Mar 2009; status: completed.
02
Drugs
ASP-001
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00872170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872170.